MHRA

News

Two hands pointing to each other index finger to index finger in a Chinese puzzle, on dark blue background

Joint MHRA/NICE pathway 'benefits industry over patients'

LSE pharma policy expert contends the MHRA/NICE aligned pathway is weighted towards industry, and calls for an assessment of its impact on the NHS.

Market Access

Health, growth & renewal: ABPI 2026 looks to UK’s future

The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.

News

UK says it has hit target on commercial trial set-up times

The UK has made progress in its efforts to slash set-up times for clinical trials, one of the factors blamed for a decline in industry-backed studies.

News

First MHRA/NICE aligned guidance due in June

The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.

News

Man with measuring tape around his torso

GLP-1 drugs linked to pancreatitis, gallbladder problems

Users of weight-loss therapies based on GLP-1 agonists have been warned to be aware of a rare complication, pancreatitis, that can be severe.

News

JPM: Is the UK's clinical trials sector turning a corner?

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

Joint MHRA/NICE pathway 'benefits industry over patients'

Health, growth & renewal: ABPI 2026 looks to UK’s future

UK says it has hit target on commercial trial set-up times

First MHRA/NICE aligned guidance due in June

GLP-1 drugs linked to pancreatitis, gallbladder problems

JPM: Is the UK's clinical trials sector turning a corner?

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

MHRA

Editor's Picks